Medical Letter on the CDC & FDA
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Letter on the CDC & FDA
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Diagnostics
CAD technology agreement with 3D imaging partner TeraRecon broadened
October 23rd, 2005
ICAD, Inc. (ICAD), a provider of computer-aided detection (CAD) system that enable identifidation of cancer and other life-threatening conditions, announced the broadening of its technology partnership with TeraRecon, Inc., a provider of advanced image processing and 3D visualization techniques. Under the terms of the agreement, iCAD will integrate with TeraRecon's Aquarius 3D tools its Computed Tomography (CT) Colon CAD software for the identification of potential polyps in CT Colonography (CTC) images. TeraRecon is developing a new image processing server to work in concert with existing PACS and DICOM review equipment, which will include iCAD's detection software...
Source: Medical Letter on the CDC & FDA (2005-10-23)
|
